J Clin Med. 2025 Aug 31;14(17):6164. doi: 10.3390/jcm14176164. ABSTRACT Objectives: Connective tissue diseases (CTDs) include a diverse group of systemic […]
J Clin Med. 2025 Aug 28;14(17):6090. doi: 10.3390/jcm14176090. ABSTRACT Background/Objectives: The combination of denosumab treatment with biological disease-modifying antirheumatic drugs
J Clin Med. 2025 Aug 27;14(17):6058. doi: 10.3390/jcm14176058. ABSTRACT BACKGROUND/OBJECTIVES: Musculoskeletal disorders causing chronic pain are increasingly prevalent due to
J Clin Med. 2025 Aug 26;14(17):6038. doi: 10.3390/jcm14176038. ABSTRACT Background: Altered microbiome structures are perceived as one of the factors
J Clin Med. 2025 Aug 22;14(17):5923. doi: 10.3390/jcm14175923. ABSTRACT Background: Establishing a highly accurate regional medical collaboration (RMC) system for
Int J Mol Sci. 2025 Sep 8;26(17):8741. doi: 10.3390/ijms26178741. ABSTRACT To evaluate the analytical performance and clinical utility of the
Int J Mol Sci. 2025 Sep 4;26(17):8613. doi: 10.3390/ijms26178613. ABSTRACT Swiprosin-1 (SWS1/EFhd2) is a calcium-binding adaptor protein involved in cytoskeletal
Nat Microbiol. 2025 Sep 12. doi: 10.1038/s41564-025-02143-z. Online ahead of print. NO ABSTRACT PMID:40940566 | DOI:10.1038/s41564-025-02143-z
Sci Rep. 2025 Sep 12;15(1):32419. doi: 10.1038/s41598-025-13922-3. ABSTRACT Endoprosthesis loosening is the major cause of arthroplasty failure. Currently, radiography, histo-pathological
Clin Pediatr (Phila). 2025 Sep 12:99228251372758. doi: 10.1177/00099228251372758. Online ahead of print. ABSTRACT Thirty adolescents (15 female) with familial Mediterranean
Ann Rheum Dis. 2025 Sep 11:S0003-4967(25)04317-1. doi: 10.1016/j.ard.2025.08.018. Online ahead of print. ABSTRACT OBJECTIVES: This study aims to conduct a
Ann Rheum Dis. 2025 Sep 11:S0003-4967(25)04311-0. doi: 10.1016/j.ard.2025.08.012. Online ahead of print. ABSTRACT OBJECTIVES: Despite expanding regulatory T (Treg) cells,
Autoimmun Rev. 2025 Sep 10:103934. doi: 10.1016/j.autrev.2025.103934. Online ahead of print. ABSTRACT BACKGROUND: Sphingosine-1-phosphate receptor (S1PR) modulators are approved as
J Allergy Clin Immunol. 2025 Sep 10:S0091-6749(25)00943-1. doi: 10.1016/j.jaci.2025.08.026. Online ahead of print. ABSTRACT BACKGROUND: Prurigo Nodularis (PN) is a
… rheumatology care may enhance prognostic evaluation, guide personalized treatment, and support interdisciplinary management strategies for …
Lessons Learned in Neuropsychiatric SLE Dr. Sheila Reyes, The Philippines, reports highlights from a session on neurop https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
Patients with inflammatory rheumatic diseases are at increased risk of infection and severe outcomes—a risk that is further compounded by
JAMA Dermatol. 2025 Aug 6. doi: 10.1001/jamadermatol.2025.2665. Online ahead of print. ABSTRACT IMPORTANCE: Cutaneous vasculitis (CV) is a heterogenous and
J Holist Nurs. 2025 Sep 12:8980101251376863. doi: 10.1177/08980101251376863. Online ahead of print. ABSTRACT Polypharmacy is problematic in patients with fibromyalgia.
Am J Case Rep. 2025 Sep 12;26:e948700. doi: 10.12659/AJCR.948700. ABSTRACT BACKGROUND Granulomatosis with polyangiitis (GPA) is a rare systemic vasculitis
Cell Rep. 2025 Sep 10;44(9):116256. doi: 10.1016/j.celrep.2025.116256. Online ahead of print. ABSTRACT Tregs are critical regulators of the immune response,
J Am Soc Nephrol. 2025 Sep 12. doi: 10.1681/ASN.0000000866. Online ahead of print. ABSTRACT BACKGROUND: Recent studies suggest that oral
PAH diagnosis and management in the context of CTD ILD Pulmonary arterial hypertension (PAH) is a serious complication https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Immune-related rheumatic adverse effects (rheumatic IAEs) are … He presented to the rheumatology office with joint pain and swelling in …
QD Clinic Video: RA and Bronchiectasis Dr. Jeffrey Sparks, Boston, talks about rheumatoid arthritis and bronchiectasis https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 09/12/2025
STOP-RA results published in A&R. 144 at risk, CCP+ pts were enrolled to received HCQ vs PBO for 12 mos,
TNR: Future Treatment of ILD This Tuesday Night Rheumatology webinar reviewed ACR and EULAR guidelines on interstitial https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
